SCHEMBL9433255

SCHEMBL9433255

O=C(C=Cc1c(C(=O)O)[nH]c2cc(Cl)cc(Cl)c12)NCc1ccccc1

nearest known ligand 0.71

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
GPR17 Q13304 1/20 0.71
GRIN1 Q05586 5/20 0.60
ALOX15 P16050 2/20 0.59
MEN1 O00255 2/20 0.59
KMT2A Q03164 2/20 0.59
KDM4E B2RXH2 1/20 0.59
ALDH1A1 P00352 1/20 0.59
CYP3A4 P08684 1/20 0.59
MAPT P10636 1/20 0.59
HPGD P15428 1/20 0.59
TSHR P16473 1/20 0.59
ALOX12 P18054 1/20 0.59
HSD17B10 Q99714 1/20 0.59
LMNA P02545 1/20 0.54
CYP1A2 P05177 1/20 0.54
MAPK1 P28482 1/20 0.54
BLM P54132 1/20 0.54
PMP22 Q01453 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9433248 1.00 GPR17 (0.71) GPR17GRIN1ALOX15MEN1KMT2A
SCHEMBL18623465 0.84 GPR17 (0.73) GPR17ALOX15MEN1KMT2AKDM4E
Gavestinel SCHEMBL678632 0.83 GPR17 (1.00) GPR17GRIN1ALOX15MEN1KMT2A
Gavestinel SCHEMBL30184856 0.83 GPR17 (1.00) GPR17GRIN1ALOX15MEN1KMT2A
Gavestinel SCHEMBL1721070 0.83 GPR17 (1.00) GPR17GRIN1ALOX15MEN1KMT2A
Gavestinel SCHEMBL1995818 0.82 GPR17 (0.98) GPR17GRIN1ALOX15MEN1KMT2A
Gavestinel SCHEMBL1995817 0.82 GPR17 (0.98) GPR17GRIN1ALOX15MEN1KMT2A
Gavestinel SCHEMBL1995813 0.82 GPR17 (0.98) GPR17GRIN1ALOX15MEN1KMT2A
SCHEMBL9709075 0.80 GPR17 (0.71) GPR17GRIN1ALOX15MEN1KMT2A
SCHEMBL9709067 0.80 GPR17 (0.71) GPR17GRIN1ALOX15MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5284862-A Neurodegenerative disorders including cerebrovascular disorders; antagonists for excitatory amino acid receptors WARNER-LAMBERT COMPANY (US) 1994-02-08 US claimed
WO-1992016205-A2 NOVEL DERIVATIVES OF 2-CARBOXYNDOLES HAVING PHARMACEUTICAL ACTIVITY WARNER-LAMBERT COMPANY (US) 1992-10-01 WO claimed